Browsing: 2025 – November
A convergence of themes has contributed to the growth story of the US life and annuity market of the past few years.
Longevity and Mortality Investor’s Editor’s Letter for the November 2025 issue.
The buy-in, completed in June 2025, insures the benefits of all 30 members – 15 deferred and 15 pensioners.
The transactions, completed in July 2025, secure the benefits of approximately 980 members across the two schemes.
The deal secures the future benefits of 300 pension scheme members – 160 deferred members and 140 pensioners.
The subject of whether life insurance-linked securities (life ILS) structures should be rated or not is a conversation almost as old as the market itself.
Traditionally, PRT transactions in the US are of the buy-out variety, a trend driven by the economics of no longer having to administer participants after the deal closes and the expenses associated with it. However, there is evidence to suggest that the buy-in variety is growing in popularity.
Litigation risk in the life settlement market takes multiple forms, from cost of insurance increases to estate challenges, from credit risk to stranger-owned life insurance cases. Liam Bodemeaid, Actuarial Consultant at Actuarial Risk Management, introduces a new framework to price litigation risk with a little bit more logic, data, and structure in a guest article.
The longevity economy is multi-faceted, with a range of investment opportunities available that can impact longevity in different ways. Greg Winterton spoke to Sergey Jakimov, Founding Partner of venture capital firm LongeVC, to get his views on both the space overall, and how LongeVC sees it, and therefore, approaches it in our latest Q&A.